
Acceleron Pharma Inc.
CEO
Habib Dable
IPO Date
2013-09-18
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 20,000 |
| $41.48 |
| 22 Nov 2021 | Nader Francois | director | D-Return | Disposed | 7,500 | $41.64 |
| 22 Nov 2021 | Nader Francois | director | D-Return | Disposed | 8,185 | $52.99 |
| 22 Nov 2021 | Nader Francois | director | D-Return | Disposed | 3,222 | $115.53 |
| 22 Nov 2021 | Nader Francois | director | U-Tender | Disposed | 6,749 | $180.00 |
| 22 Nov 2021 | Nader Francois | director | D-Return | Disposed | 10,000 | $27.97 |
| 22 Nov 2021 | Nader Francois | director | D-Return | Disposed | 7,500 | $30.17 |
| 22 Nov 2021 | Nader Francois | director | D-Return | Disposed | 10,000 | $34.14 |
| 22 Nov 2021 | Nader Francois | director | D-Return | Disposed | 7,500 | $40.61 |